Status:
TERMINATED
Lung Allograft Rejection Gene Expression Observational (LARGO) Study
Lead Sponsor:
XDx
Conditions:
Graft Rejection
Lung Disease
Eligibility:
All Genders
Brief Summary
The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perform molecular...
Detailed Description
LARGO is a prospective, multi-center, international observational study with participating centers in the United States, Canada and Europe. The target enrollment for study completion is 2,100 subjects...
Eligibility Criteria
Inclusion
- Lung and heart-lung transplant recipients who consent to participate and have transbronchial biopsy at the enrolling center during the study period
Exclusion
- None
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
2044 Patients enrolled
Trial Details
Trial ID
NCT00751309
Start Date
April 1 2004
End Date
January 1 2009
Last Update
December 18 2008
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Division of Pulmonary and Critical Care
Los Angeles, California, United States, 90095
2
University of California, San Francisco
San Francisco, California, United States, 94117
3
Stanford University School of Medicine
Stanford, California, United States, 94305
4
University of Colorado
Aurora, Colorado, United States, 80045